Literature DB >> 23836418

A combined biochemical, biophysical and immunological approach towards the identification of celiac disease-specific wheat antigens.

Bharani Srinivasan1, Margarete Focke-Tejkl, Ines Swoboda, Claudia Constantin, Irene Mittermann, Sandra Pahr, Harald Vogelsang, Wolf-Dietrich Huber, Rudolf Valenta.   

Abstract

Celiac disease (CD) is an inflammatory affliction of the small bowel caused by an immunological hypersensitivity to ingested wheat antigens affecting almost 1 % of the population. The gliadin fraction of wheat has been shown to contain the pathogenic antigens which react with antibodies and T cells. However, there is only limited knowledge regarding the precise nature of the wheat antigens recognized by IgA antibodies from CD patients and diagnostic tests based on the gliadin fraction have been demonstrated to give frequently false positive results. The aim of this study was the characterization of wheat antigens specifically recognized by IgA antibodies of CD patients. We developed a combined biochemical, biophysical, and immunological approach for the identification of celiac disease-specific wheat antigens. It is based on sub-fractionation of the wheat gliadin fraction using two ion exchange chromatography steps, the localization of CD-specific antigens by immunoblotting with IgA antibodies from CD patients, subsequent digestion followed by electro spray ionization-liquid chromatography/mass spectrometry (LC-ESI-MS/MS) and N-terminal sequencing by Edman degradation. Through the sub-fractionation procedure it was possible to separate CD-specific IgA-reactive wheat antigens from other wheat antigens which were also recognized by IgA antibodies of individuals without CD or by CD patients on gluten-free diet. Analysis by LC-ESI-MS/MS and N-terminal sequencing of the sub-fractions and the proteins specifically recognized by CD patients identified certain γ-gliadins with molecular mass of 37,000 and 45,000 as CD-specific wheat antigens. The CD-specific γ-gliadins with the molecular mass of 37,000 and 45,000 should be useful to study pathomechanisms of the disease and to improve the specificity of diagnostic tests for CD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23836418     DOI: 10.1007/s00726-013-1537-6

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  5 in total

1.  Usefulness of recombinant γ-gliadin 1 for identifying patients with celiac disease and monitoring adherence to a gluten-free diet.

Authors:  Bharani Srinivasan; Margarete Focke-Tejkl; Milena Weber; Sandra Pahr; Alexandra Baar; Raja Atreya; Markus F Neurath; Harald Vogelsang; Wolf-Dietrich Huber; Rudolf Valenta
Journal:  J Allergy Clin Immunol       Date:  2015-06-13       Impact factor: 10.793

2.  Resistance of parvalbumin to gastrointestinal digestion is required for profound and long-lasting prophylactic oral tolerance.

Authors:  Raphaela Freidl; Antonia Gstöttner; Ulrike Baranyi; Ines Swoboda; Frank Stolz; Margarete Focke-Tejkl; Thomas Wekerle; Ronald van Ree; Rudolf Valenta; Birgit Linhart
Journal:  Allergy       Date:  2019-10-03       Impact factor: 13.146

3.  Changes in Non-Deamidated versus Deamidated Epitope Targeting and Disease Prediction during the Antibody Response to Gliadin and Transglutaminase of Infants at Risk for Celiac Disease.

Authors:  Ádám Diós; Bharani Srinivasan; Judit Gyimesi; Katharina Werkstetter; Rudolf Valenta; Sibylle Koletzko; Ilma R Korponay-Szabó
Journal:  Int J Mol Sci       Date:  2022-02-24       Impact factor: 5.923

4.  Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip.

Authors:  Christian Lupinek; Eva Wollmann; Alexandra Baar; Srinita Banerjee; Heimo Breiteneder; Barbara M Broecker; Merima Bublin; Mirela Curin; Sabine Flicker; Tetiana Garmatiuk; Heidrun Hochwallner; Irene Mittermann; Sandra Pahr; Yvonne Resch; Kenneth H Roux; Bharani Srinivasan; Sebastian Stentzel; Susanne Vrtala; Leanna N Willison; Magnus Wickman; Karin C Lødrup-Carlsen; Josep Maria Antó; Jean Bousquet; Claus Bachert; Daniel Ebner; Thomas Schlederer; Christian Harwanegg; Rudolf Valenta
Journal:  Methods       Date:  2013-10-22       Impact factor: 3.608

5.  Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction.

Authors:  Ádám Diós; Rita Elek; Ildikó Szabó; Szilvia Horváth; Judit Gyimesi; Róbert Király; Katharina Werkstetter; Sibylle Koletzko; László Fésüs; Ilma R Korponay-Szabó
Journal:  Amino Acids       Date:  2021-05-31       Impact factor: 3.520

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.